Literature DB >> 21416133

Incidence of vasculopathy in children with hypothalamic/chiasmatic gliomas treated with brachytherapy.

U Tacke1, D Karger, J Spreer, A Berlis, G Nikkhah, R Korinthenberg.   

Abstract

INTRODUCTION: External brain irradiation in children can cause cognitive decline, endocrine dysfunctions and second malignancies. A rare complication is cerebral vasculopathy, which occurs most often in patients with neurofibromatosis type 1. Interstitial radiotherapy using transient Iodine-125 implants is a radiotherapy option, called brachytherapy, offering excellent survival rates, but little is known on treatment-related morbidity, especially long time vascular changes. PATIENTS AND METHODS: Thirteen children with low-grade hypothalamic gliomas, four of them with neurofibromatosis type 1, were diagnosed and treated at the University Hospital Freiburg, Germany. They belong to a larger group of 44 children with suprasellar low-grade gliomas, treated with transient Iodine-125 seeds and include those who attended all routine follow-up examinations in Freiburg. After written informed consent from the parents or caregivers all patients underwent magnetic resonance imaging with angiographic techniques in 2001, 3 to 13 years after treatment. RESULTS AND DISCUSSION: Six out of 13 revealed cerebral vasculopathies, only one of them revealed symptoms of intermittent cerebral ischemia. Neurofibromatosis type 1 was present in one affected patient. The aetiology of the cerebral vascular changes is not fully understood so far. Tumour encasement, surgical damage and brachytherapy may contribute as a single risk factor or in combination. To get more information, we recommend MRA for artery vasculopathy at follow-up in all patients with suprasellar brain tumours irrespectively to their former treatment or presence of cerebrovascular symptoms.

Entities:  

Mesh:

Year:  2011        PMID: 21416133     DOI: 10.1007/s00381-010-1370-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  22 in total

1.  [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].

Authors:  A K Gnekow; P Kaatsch; R Kortmann; O D Wiestler
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

2.  Magnetic resonance angiography in childhood arterial brain infarcts: a comparative study with contrast angiography.

Authors:  Béatrice Husson; Georges Rodesch; Pierre Lasjaunias; Marc Tardieu; Guillaume Sébire
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

3.  Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).

Authors:  A K Gnekow; R-D Kortmann; T Pietsch; A Emser
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

4.  Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma.

Authors:  J Grill; D Couanet; C Cappelli; J L Habrand; D Rodriguez; C Sainte-Rose; C Kalifa
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

Review 5.  Brain tumors across the age spectrum: biology, therapy, and late effects.

Authors:  Thomas E Merchant; Ian F Pollack; Jay S Loeffler
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

6.  Outcome analysis of childhood low-grade astrocytomas.

Authors:  Paul G Fisher; Tarik Tihan; Patricia T Goldthwaite; Moody D Wharam; Benjamin S Carson; Jon D Weingart; Michael X Repka; Kenneth J Cohen; Peter C Burger
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

7.  Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors.

Authors:  Stacy Wentworth; Melva Pinn; J Daniel Bourland; Allan F Deguzman; Kenneth Ekstrand; Thomas L Ellis; Steven S Glazier; Kevin P McMullen; Michael Munley; Volker W Stieber; Stephen B Tatter; Edward G Shaw
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-05       Impact factor: 7.038

8.  Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases.

Authors:  Carla Fernandez; Dominique Figarella-Branger; Nadine Girard; Corinne Bouvier-Labit; Joanny Gouvernet; Armando Paz Paredes; Gabriel Lena
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

Review 9.  Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.

Authors:  B Morris; S Partap; K Yeom; I C Gibbs; P G Fisher; A A King
Journal:  Neurology       Date:  2009-10-07       Impact factor: 9.910

Review 10.  Late complications in childhood central nervous system tumour survivors.

Authors:  Neil E Anderson
Journal:  Curr Opin Neurol       Date:  2003-12       Impact factor: 5.710

View more
  6 in total

1.  Suprasellar pilocytic astrocytoma: one national centre's experience.

Authors:  Tafadzwa Mandiwanza; Chandrasekaran Kaliaperumal; Ayman Khalil; Muhammad Sattar; Darach Crimmins; John Caird
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

2.  Large Vessel Arteriopathy After Cranial Radiation Therapy in Pediatric Brain Tumor Survivors.

Authors:  Matthew Nordstrom; Erin Felton; Katherine Sear; Benita Tamrazi; Joseph Torkildson; Karen Gauvain; Daphne A Haas-Kogan; Josephine Chen; Benedict Del Buono; Anuradha Banerjee; David Samuel; David Saloner; Bing Tian; Erika Roddy; Christopher Hess; Heather Fullerton; Sabine Mueller
Journal:  J Child Neurol       Date:  2018-04       Impact factor: 1.987

3.  Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.

Authors:  Astrid K Gnekow; Fabian Falkenstein; Stephan von Hornstein; Isabella Zwiener; Susanne Berkefeld; Brigitte Bison; Monika Warmuth-Metz; Pablo Hernáiz Driever; Niels Soerensen; Rolf-D Kortmann; Torsten Pietsch; Andreas Faldum
Journal:  Neuro Oncol       Date:  2012-08-31       Impact factor: 12.300

4.  A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

Authors:  Anuradha Banerjee; Regina I Jakacki; Arzu Onar-Thomas; Shengjie Wu; Theodore Nicolaides; Tina Young Poussaint; Jason Fangusaro; Joanna Phillips; Arie Perry; David Turner; Michael Prados; Roger J Packer; Ibrahim Qaddoumi; Sridharan Gururangan; Ian F Pollack; Stewart Goldman; Lawrence A Doyle; Clinton F Stewart; James M Boyett; Larry E Kun; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

Review 5.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

6.  Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.

Authors:  Mathias Kunz; Silke B Nachbichler; Lorenz Ertl; Gunther Fesl; Rupert Egensperger; Maximilian Niyazi; Irene Schmid; Joerg Christian Tonn; Aurelia Peraud; Friedrich Wilhelm Kreth
Journal:  Cancer Med       Date:  2015-12-29       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.